
Marcela M. Cordero Garcia
Examiner (ID: 4537)
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1676, 1658 |
| Total Applications | 1421 |
| Issued Applications | 950 |
| Pending Applications | 83 |
| Abandoned Applications | 394 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14883519
[patent_doc_number] => 10421786
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-24
[patent_title] => Peptides that target inflamed or distressed cardiac tissue and uses related thereto
[patent_app_type] => utility
[patent_app_number] => 16/012306
[patent_app_country] => US
[patent_app_date] => 2018-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 6
[patent_no_of_words] => 10248
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16012306
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/012306 | Peptides that target inflamed or distressed cardiac tissue and uses related thereto | Jun 18, 2018 | Issued |
Array
(
[id] => 15894913
[patent_doc_number] => 20200146975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => HYDROGEL DELIVERY OF STING IMMUNOTHERAPY FOR TREATMENT CANCER
[patent_app_type] => utility
[patent_app_number] => 16/618043
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16618043
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/618043 | Hydrogel delivery of sting immunotherapy for treatment cancer | Jun 14, 2018 | Issued |
Array
(
[id] => 16998385
[patent_doc_number] => 11077167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Agent for promoting skeletal muscle injury repair
[patent_app_type] => utility
[patent_app_number] => 16/619879
[patent_app_country] => US
[patent_app_date] => 2018-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 23
[patent_no_of_words] => 10475
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619879
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/619879 | Agent for promoting skeletal muscle injury repair | Jun 11, 2018 | Issued |
Array
(
[id] => 18071417
[patent_doc_number] => 11530240
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-20
[patent_title] => Catheter injectable cyclic peptide pro-gelators for myocardial tissue engineering
[patent_app_type] => utility
[patent_app_number] => 16/620025
[patent_app_country] => US
[patent_app_date] => 2018-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 31
[patent_no_of_words] => 17657
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16620025
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/620025 | Catheter injectable cyclic peptide pro-gelators for myocardial tissue engineering | Jun 10, 2018 | Issued |
Array
(
[id] => 13465171
[patent_doc_number] => 20180284128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => SRM METHODS IN ALZHEIMER'S DISEASE AND NEUROLOGICAL DISEASE ASSAYS
[patent_app_type] => utility
[patent_app_number] => 16/002123
[patent_app_country] => US
[patent_app_date] => 2018-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16002123
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/002123 | SRM METHODS IN ALZHEIMER'S DISEASE AND NEUROLOGICAL DISEASE ASSAYS | Jun 6, 2018 | Abandoned |
Array
(
[id] => 16007349
[patent_doc_number] => 20200178517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => RECRYSTALLIZATION INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 16/619676
[patent_app_country] => US
[patent_app_date] => 2018-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619676
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/619676 | Recrystallization inhibitor | Jun 4, 2018 | Issued |
Array
(
[id] => 17104363
[patent_doc_number] => 11124558
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-21
[patent_title] => Use of tetranectin and peptide agonists to treat inflammatory diseases
[patent_app_type] => utility
[patent_app_number] => 16/617811
[patent_app_country] => US
[patent_app_date] => 2018-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9680
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617811
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/617811 | Use of tetranectin and peptide agonists to treat inflammatory diseases | Jun 3, 2018 | Issued |
Array
(
[id] => 17306301
[patent_doc_number] => 11207384
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Rapid-acting insulin compositions
[patent_app_type] => utility
[patent_app_number] => 16/615894
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6835
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615894
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615894 | Rapid-acting insulin compositions | May 30, 2018 | Issued |
Array
(
[id] => 16792982
[patent_doc_number] => 20210122799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => SELF-ASSEMBLING PEPTIDE FOR ACTIVATING HUMAN MAST CELLS
[patent_app_type] => utility
[patent_app_number] => 16/617392
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14030
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617392
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/617392 | Self-assembling peptide for activating human mast cells | May 24, 2018 | Issued |
Array
(
[id] => 13957909
[patent_doc_number] => 20190055298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => ENGINEERED HIGH-AFFINITY HUMAN T CELL RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 15/990524
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15990524
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/990524 | ENGINEERED HIGH-AFFINITY HUMAN T CELL RECEPTORS | May 24, 2018 | Abandoned |
Array
(
[id] => 15928013
[patent_doc_number] => 20200155640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => LIPO-GLYCOPEPTIDE CLEAVABLE DERIVATIVES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/615214
[patent_app_country] => US
[patent_app_date] => 2018-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20710
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615214
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615214 | Lipo-glycopeptide cleavable derivatives and uses thereof | May 21, 2018 | Issued |
Array
(
[id] => 15616065
[patent_doc_number] => 20200078437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => Immunoproteasome Inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/613582
[patent_app_country] => US
[patent_app_date] => 2018-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613582
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/613582 | Immunoproteasome inhibitor | May 14, 2018 | Issued |
Array
(
[id] => 15800133
[patent_doc_number] => 20200123209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => ANTIMICROBIAL TYPE-II BACTERIOCINS
[patent_app_type] => utility
[patent_app_number] => 16/612245
[patent_app_country] => US
[patent_app_date] => 2018-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612245
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/612245 | Antimicrobial type-II bacteriocins | May 9, 2018 | Issued |
Array
(
[id] => 13444135
[patent_doc_number] => 20180273610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => MODIFIED SERPINS FOR THE TREATMENT OF BLEEDING DISORDERS
[patent_app_type] => utility
[patent_app_number] => 15/971692
[patent_app_country] => US
[patent_app_date] => 2018-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15971692
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/971692 | Modified serpins for the treatment of bleeding disorders | May 3, 2018 | Issued |
Array
(
[id] => 14015087
[patent_doc_number] => 20190069537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => Compositions and Methods for Reducing Ice Crystal Formation
[patent_app_type] => utility
[patent_app_number] => 15/969256
[patent_app_country] => US
[patent_app_date] => 2018-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22863
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15969256
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/969256 | Compositions and methods for reducing ice crystal formation | May 1, 2018 | Issued |
| 15/967504 | ABALOPARATIDE FORMULATIONS AND METHODS OF TESTING, STORING, MODIFYING, AND USING SAME | Apr 29, 2018 | Abandoned |
Array
(
[id] => 15831903
[patent_doc_number] => 20200131233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => PROTEINS AND PEPTIDE TAGS WITH ENHANCED RATE OF SPONTANEOUS ISOPEPTIDE BOND FORMATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/606818
[patent_app_country] => US
[patent_app_date] => 2018-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606818
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606818 | Proteins and peptide tags with enhanced rate of spontaneous isopeptide bond formation and uses thereof | Apr 23, 2018 | Issued |
Array
(
[id] => 16381892
[patent_doc_number] => 10806702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Bis-polymer lipid-peptide conjugates and nanoparticles thereof
[patent_app_type] => utility
[patent_app_number] => 15/961111
[patent_app_country] => US
[patent_app_date] => 2018-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 72
[patent_no_of_words] => 20577
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15961111
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/961111 | Bis-polymer lipid-peptide conjugates and nanoparticles thereof | Apr 23, 2018 | Issued |
Array
(
[id] => 15451385
[patent_doc_number] => 20200038516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => DOSING REGIMENS AND RELATED COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/500994
[patent_app_country] => US
[patent_app_date] => 2018-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -319
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500994
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500994 | Dosing regimens and related compositions and methods | Apr 8, 2018 | Issued |
Array
(
[id] => 16267343
[patent_doc_number] => 20200268830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => ANTIMICROBIAL COMPOUNDS FROM THE GENUS DELFTIA
[patent_app_type] => utility
[patent_app_number] => 16/496978
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496978
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/496978 | Antimicrobial compounds from the genus | Mar 27, 2018 | Issued |